Now showing items 1-1 of 1
Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight.
( Informa Healthcare , 2019 , Article Review)
Triple negative breast cancers (TNBCs) are aggressive heterogeneous cancers with not yet determined conventional targeted medication. Therefore, identification of new alternatives or improved treatment options to combat ...